Supernus Pharmaceuticals (SUPN) EPS (Basic) (2011 - 2025)
Supernus Pharmaceuticals' (SUPN) quarterly EPS (Basic) came in at -$0.07 in Q4 2025, down 126.14% year-on-year from $0.28 in Q4 2024, and up 90.89% on a QoQ basis from -$0.8 in Q3 2025.
Supernus Pharmaceuticals (SUPN) EPS (Basic) (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 15 years of EPS (Basic) data on file, last reported at -$0.07 in Q4 2025.
- On a quarterly basis, EPS (Basic) fell 126.14% year-over-year to -$0.07 in Q4 2025; TTM through Mar 2026 was -$0.46, a 141.81% decrease from a year earlier, with the FY2025 full-year figure at -$0.68, down 150.94% from the prior year.
- EPS (Basic) for Q4 2025 stood at -$0.07, up from -$0.8 in the prior quarter.
- Over the last five years, EPS (Basic) for SUPN reached as high as $0.7 in Q3 2024 and fell as low as -$0.8 in Q3 2025.
- Historically, EPS (Basic) has averaged $0.14 across 5 years, with a median of $0.13 in 2022.
- Across the five-year window, EPS (Basic) soared 2485.7% in 2024 and slumped 8213.26% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at $0.05 in 2021, then soared by 933.54% to $0.48 in 2022, then tumbled by 95.47% to $0.02 in 2023, then surged by 1191.16% to $0.28 in 2024, then slumped by 126.14% to -$0.07 in 2025.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.07 in Q4 2025, -$0.8 in Q3 2025, and $0.4 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.80 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 0.36 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.29 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | 0.31 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.41 |
| Jun 30, 2021 | 0.45 |
| Mar 31, 2021 | 0.11 |